Australia markets closed

Genocea Biosciences Inc (GBI1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.00050.0000 (0.00%)
At close: 08:02AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
1,911
1,641
1,359
Operating expenses
Research development
42,713
39,020
33,960
Selling general and administrative
14,642
14,714
14,388
Total operating expenses
57,355
53,734
48,348
Operating income or loss
-55,444
-52,093
-46,989
Interest expense
1,073
1,121
1,380
Total other income/expenses net
19,326
20,018
4,655
Income before tax
-37,191
-33,196
-43,714
Income from continuing operations
-37,191
-33,196
-43,714
Net income
-37,191
-33,196
-43,714
Net income available to common shareholders
-37,191
-33,196
-43,714
Basic EPS
-0.52
-0.48
-0.98
Diluted EPS
-0.52
-0.48
-1.11
Basic average shares
69,816
68,575
44,436
Diluted average shares
69,816
68,575
46,553